抗精神病薬の比較受容体薬理は,正常化された結合親和データと相互作用の幅に基づいています
Christian Lange-Asschenfeldt1, Katja Brouzou2, Julia Christl2
1Department of Psychiatry and Psychotherapy, Medical Faculty, Heinrich Heine University, Düsseldorf, Germany; Department of Forensic Psychiatry, LVR-Klinik Langenfeld, Germany.
まとめ
この研究は,抗精神病薬 (APD) の受容体相互作用の幅を定量化し,三循環構造における広範な相互作用を発見したが,臨床効果との直接的な関連はない. 神経科学に基づく分類 (NbN) は,これらの発見と完全に一致しなかった.
科学分野:
- 薬理学について
- 神経科学
- 薬剤化学
背景:
- 抗精神病薬 (APD) は,幅広い受容体相互作用スペクトルを持つ複雑な薬理学を示しています.
- これらの相互作用を理解することは,薬剤の有効性と分類に極めて重要です.
研究 の 目的:
- APD受容体への結合 afinity の参照を作成する.
- APDの受容体相互作用の幅を定量化するために.
- 臨床効果と薬物の分類に対する受容体相互作用幅の影響を分析する.
主な方法:
- オープンソースのデータベースを利用して APDの結合関係を調べました
- 交叉化合物比較と幅の定量化のための標準化された親和データ.
- 臨床的有効性,化学的構造,神経科学に基づく分類 (NbN) と相関する受容体相互作用幅.
主要な成果:
- 25の受容体で35のAPDの正常化された親和感プロファイルを計算した.
- トリサイクル構造と関連した高い受容体相互作用幅を発見した.
- 受容器の相互作用幅と臨床有効性との間には直接的な相関は見られなかった.
- NbN分類は,受容体グループ関連幅の統計的分析と限られた対応を示した.
結論:
- よく使用されるAPDの包括的なマルチ受容体プロファイルを提供します.
- APDと受容体グループ間の受容体相互作用幅を比較するための定量的な方法を提供します.
- APDの薬理学の複雑さを強調しています.
関連する概念動画
01:21Antipsychotic Drugs: Typical and Atypical Agents
314
Antipsychotic drugs are classified into first-generation (typical) drugs including phenothiazines; and second-generation (atypical) drugs. Chlorpromazine hydrochloride (Thorazine), a phenothiazine derivative, broadly impacts the central, autonomic, and endocrine systems. This drug, along with typical agents like haloperidol (Haldol), primarily works by antagonizing D2 receptors, thus reducing dopaminergic neurotransmission. However, typical antipsychotics can cause side effects such as sedation...
314
01:29Drug-Receptor Interactions
6.0K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
6.0K
01:30Quantitative Aspects of Drug-Receptor Interaction
1.2K
The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower...
1.2K
01:28Drug-Receptor Interaction: Antagonist
3.4K
An antagonist is a drug that binds strongly to a receptor without activating it. An antagonist prevents other molecules, such as neurotransmitters or hormones, from binding to the receptor and triggering a cellular response. Such interaction effectively hinders the normal physiological processes mediated by the receptor, resulting in various pharmacological effects depending on the specific receptor targeted.
Antagonists can be classified as competitive or noncompetitive based on their...
Antagonists can be classified as competitive or noncompetitive based on their...
3.4K
01:29The Two-State Receptor Model
2.4K
The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with...
The binding affinity of a drug determines its interaction with...
2.4K
01:25Drug-Receptor Interaction: Agonist
2.8K
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
2.8K